InTandem Capital Partners

InTandem executes buyout and growth equity investments in lower middle-market healthcare services companies across North America. The firm seeks control or significant minority positions in cash-flow-positive businesses where its internal operational team can drive improvements in management infrastructure, revenue cycle performance, and growth systems. Target sub-sectors have historically included physician practice management, home-based care models, and specialized provider organizations.

The firm sources through a network of healthcare-specialist investment banks, industry intermediaries, and direct relationships with founder-owners and management teams. InTandem's focus on the lower middle market means it pursues transactions that are often below the threshold of larger healthcare private equity firms, positioning it as a partner for owners seeking a buyer with specific operational capabilities rather than purely financial backing. The firm has also executed corporate carve-outs as platforms for future consolidation.

No. InTandem Capital Partners is exclusively focused on the healthcare services sector. The firm does not pursue investments in healthcare information technology, biotechnology, pharmaceuticals, or medical devices as standalone opportunities, though some portfolio companies may incorporate technology enablement as part of their service delivery model. InTandem's domain specialization extends to sub-sectors such as physician services, home health, and care management organizations.

InTandem embeds in-house operating professionals within its investment team to work alongside portfolio company management on post-close strategic initiatives. The firm emphasizes operational engagement — improving revenue cycle management, building out management teams, scaling through add-on acquisitions, and investing in technology infrastructure — rather than relying primarily on financial leverage or multiple expansion. This 'active partnership' model is designed to accelerate growth and operational maturity during the hold period.

InTandem Capital Partners operates as an institutional private equity firm that raises committed capital through fund vehicles from external limited partners. It is not a single family office or a multi-family office. The firm markets its funds to institutional allocators including endowments, foundations, pension funds, and family offices that seek specialized exposure to lower middle-market healthcare services.

InTandem invests in healthcare services companies headquartered in the United States, with a focus on regional and multi-site platforms that can be scaled across multiple markets. The firm has historically sourced opportunities throughout the country, with a concentration in areas where healthcare delivery fragmentation presents consolidation opportunities. It does not pursue international or emerging-market healthcare investments.

The firm deploys capital through traditional closed-end commingled private equity funds structured as limited partnerships. These vehicles pool commitments from institutional investors and deploy capital over an investment period, with realized returns distributed upon exits. InTandem targets control and significant minority positions and has historically held investments for multi-year periods consistent with lower middle-market operational value creation timelines.